This contribution book is a collection of reviews and original articles from eminent experts working in the multi- and interdisciplinary arena of biomaterials, ranging from their design to novel uses. From their personal experience, the readers can obtain a stimulating foresight on the potentialities of different synthetic and engineered biomaterials. 21 chapters have been organized to illustrate different aspects of biomaterials science.
As health care providers, we spend our lives searching for treatments
that reduce suffering and lengthen the lives of our patients. Sometimes
we find solutions in surprising places. Although we all have hopes for
advancements in technology, the future of medicine is also about
challenging preconceptions as we change our healing biases. In many
ways, this is the natural evolution of “global medicine.” We have global
communications and global banking; however, until recently medicine
has remained remarkably provincial.
(BQ) Part 2 book "Advances in hemodynamic research" presents the following contents: Congenital heart disease and circulatory physiology, hemodynamics in coronary arterial disease and myocardial perfusion, application to cardiovascular surgery, reperfusion hemodynamics as an early predictor of cardiac function in a DCDD setting,...
Rapid Prototyping is a promising powerful technology that has the potential to
revolutionise certain spheres in the ever changing and challenging field of medical science.
The process involves building of prototypes or working models in relatively short time to
help create and test various design features, ideas, concepts, functionality and in certain
instances outcome and performance.
Interventional cardiovascular medicine has evolved from an
extremely crude method of opening femoral arteries initiated
by Dotter, to a fi eld that has now been recognized as having
a suffi cient fund of knowledge to require boards sanctioned
by the American Board of Internal Medicine. From Andreas
Gruentzig’s development of the noncompliant balloon method,
we have seen an explosion of bioengineering technology.
Cardiovascular emergencies account for 30–40% of an acute
medical workload that has grown inexorably over the last two
decades. The same period has also witnessed unprecedented
changes in the classification, investigation and treatment of
acute cardiac problems, driven by advances in basic sciences,
pharmacology and technology, but above all by a proliferating
body of evidence from controlled trials.
The idea when we started was to collect the core Emergency Medicine
information and present it in an abbreviated, succinct manner, useful to
housestaff and medical students. As we progressed it became obvious that
the very breadth of the specialty prevented any one person from accomplishing
this task. It also became obvious that our specialty had advanced past the
point where succinctness was possible. We peeled, boiled and pared, and
came up with this. We hope you find it useful.
Given the complexity of critical care practice today, it’s
impossible for even experienced clinicians to remember
all the information required to give safe and effective care
to critically ill patients. Clinicians frequently need to use a
variety of clinical resources to verify drug information,
normal laboratory and physiologic values, ECG and hemodynamic
monitoring information, emergency algorithms,
and other essential facts of patient management.
No one industry alone can provide the basis for major gains in renewable
resource chemical use. Although exciting research opportunities exist in areas
such as biopolymers, stereospecific molecules, new enzymes, novel materials,
and transgenic design, progress in isolated technical areas will not be sufficient.
We must take a broad view of future consumer needs and emphasize inter-
related research projects conducted in a parallel and coordinated manner.
Therefore, this book tried to incorporate into its own matrix the crucial issues that are
recent contributions to learning less frequent topics, with very promising therapy
approaches. So the aim and the project was at the final the scope of the title “Allergic
diseases - highlights in the clinic, mechanisms and treatment”, since it would not be
possible to materialize a project that seeks to be a formal Medical Treaty covering the
full breadth and complexity of allergy. Nevertheless, this book provides an accurate
and current learning of many clinical issues....
The new millennium has seen the birth of a new perspective that conflates research in solid-state physics, biological science as well
as materials engineering. The perspective is one that recognizes that
future new advances in all these areas will be based on a fundamental
understanding of the atomic and molecular infrastructure of
materials that has resulted from two centuries of chemistry. Major
advances will be achieved when the novel behavior, in particular the
quantum mechanical behavior, that nanoscale structures possess, can
be controlled and harnessed....
Edited by: Branislav BaskotISBN 978-953-307-675-1, Hard cover, 414 pagesPublisher: InTechPublication date: September 2011Subject: Cardiology and Cardiovascular Medicine In the intervening 10 years tremendous advances in the field of cardiac computed tomography have occurred. We now can legitimately claim that computed tomography angiography (CTA) of the coronary arteries is available. In the eval......
The discussion below describes the physical effects of key air pollutants on human
health. This discussion is mostly based on Morgan and Jalaludin’s (2001) review.
Where possible, sensitive subgroups in the population have been identified, including
people with existing disease (mainly respiratory and cardiovascular), people with
infections such as influenza and pneumonia, asthmatics, the elderly and children.
Exposure-response estimates for the key pollutants are presented in Appendix 3.
Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học General Psychiatry cung cấp cho các bạn kiến thức về ngành y đề tài: Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis...
Human genetics is the medical field with the most rapid and, one can say, overwhelming
progress. The medical practitioner constantly needs to be up-to-date on the newest developments
in his field. The diversity and rapid dynamics of advancements in genetics can sometimes
overcome the assimilation possibilities of one person; thus, overspecialization for narrowing
and deepening the research focus is needed. Consequently, expert opinion is much
valued. This book aims to provide exactly such opinions regarding several genetic diseases.
The National Institute of General Medical Sciences is committed
to encouraging and supporting basic biomedical and behavioral
research in which scientists explore the unknown. Important
medical advances have grown from the pursuit of curiosity about
fundamental questions in biology, physics, and chemistry.1 For example:
n A scientist studying marine snails found a powerful
new drug for chronic pain.
n Studying how electricity affects microbes led to a
widely used cancer medicine.
Heart disease is one of several cardiovascular diseases, which
are diseases of the heart and blood vessel system. Other
cardiovascular diseases include stroke, high blood pressure,
and rheumatic heart disease.
One reason some women aren’t too concerned about heart
disease is that they think it can be “cured” with surgery. This is
a myth. Heart disease is a lifelong condition—once you get it,
you’ll always have it. True, procedures such as bypass surgery
and angioplasty can help blood and oxygen flow to the heart
An equally important point is how the funds mobilised/owned by the
companies are being utilised. In a study conducted at the ISID it was noticed that
companies of different sizes extended loans to or invested in other enterprises in a
big way. Such phenomenon is more prevalent in profit-making companies. Within
the profit-making companies those who increased their borrowings invested
relatively more than the rest. There is growing importance of group companies and
non-marketable securities as also advances to group companies in such outside